#21. N-of-1: the Future of Personalized Drug Development
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
#21. N-of-1: the Future of Personalized Drug Development
-
Narrated by:
-
By:
About this listen
This episode of the podcast explores how Artificial Intelligence (AI) and N-of-1 trials are revolutionizing personalized drug development. Moving beyond population-based models, N-of-1 trials enable highly tailored therapies, especially for rare diseases. The discussion highlights AI’s role across the pipeline—from target discovery and molecule design to synthesis prediction and personalized treatment optimization. It also addresses challenges like data privacy, regulatory gaps, and scalability. Together, AI and N-of-1 approaches promise a future of faster, patient-specific drug development. Produced by Dr. Jake Chen.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.